hormoneInjectableControlledSchedule III (US, Anabolic Steroids Control Act)Prescription only (US)FDA-approved for diagnosed hypogonadism with confirmed low serum testosterone and associated symptoms, not for age-related decline aloneTRAVERSE found testosterone non-inferior to placebo for major adverse cardiac events but with higher rates of atrial fibrillation, acute kidney injury and pulmonary embolism
Testosterone (TRT)Benefits, Dosage & Interactions
Also known as: trt, testosterone cypionate
Testosterone is a steroid hormone primarily produced in the testes of males and, in smaller amounts, in the ovaries of females and the adrenal glands in both sexes. Research on Testosterone (TRT) focuses on testosterone support, cognition and mood, and libido.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial and regulatory approval on file.
Plasma half-life
Not established
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The TRAVERSE trial titrated topical testosterone gel to restore mid-normal serum testosterone (typically the equivalent of 1.62% gel starting doses); other reviewed regimens use injectable esters dosed to trough levels[1][2][3]
- Route studied
- Topical gel in the TRAVERSE trial; injectable and other FDA-approved formulations are discussed in the clinical reviews[1][2][3]
Reported for Testosterone (TRT) in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Testosterone (TRT) entry is written from. Each number matches an inline marker above.
- [1]Cardiovascular Safety of Testosterone-Replacement TherapyLincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, et al. · The New England Journal of Medicine · 2023 · Peer-reviewed · PMID 37326322
- [2]Testosterone Replacement Therapy for Male HypogonadismHeidelbaugh JJ · American Family Physician · 2024 · Peer-reviewed · PMID 38905552
- [3]Testosterone replacement therapyBarbonetti A, D'Andrea S, Francavilla S · Andrology · 2020 · Peer-reviewed · PMID 32068334
How to track Testosterone (TRT) doses
Testosterone (TRT) is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Testosterone (TRT) is stored as a concentration rather than a guess. DoseRoutine converts that into mg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Testosterone (TRT) comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Testosterone (TRT) alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
What is Testosterone (TRT) studied for?
What is Testosterone (TRT)?
Testosterone is a steroid hormone primarily produced in the testes of males and, in smaller amounts, in the ovaries of females and the adrenal glands in both sexes. It plays a crucial role in the development of male reproductive tissues such as the testes and prostate, as well as promoting secondary sexual characteristics like increased muscle and bone mass, and the growth of body hair. Testosterone also plays a significant role in overall health, contributing to energy levels, mood, cognitive function, and red blood cell production.
Testosterone Replacement Therapy (TRT) involves administering exogenous testosterone to individuals with clinically low testosterone levels, a condition often referred to as hypogonadism. Hypogonadism can result from various medical conditions affecting the testes or pituitary gland. The goal of TRT is to restore testosterone levels to a physiological range, alleviating symptoms associated with testosterone deficiency. (NIH National Institute of Diabetes and Digestive and Kidney Diseases).
TRT is available in several forms, including injections (e.g., testosterone cypionate, enanthate), transdermal patches, gels, oral capsules, and subdermal pellets. The choice of formulation depends on individual patient factors and clinician preference. Treatment with TRT is typically long-term and requires regular monitoring by a healthcare professional to assess efficacy, manage potential side effects, and adjust dosing as necessary. (Mayo Clinic)
What does the research say about Testosterone (TRT)?
Tap a section to expand.
Testosterone, as an androgen, primarily exerts its effects by binding to the androgen receptor (AR) located in target cells throughout the body. Upon binding, the testosterone-androgen receptor complex translocates to the cell nucleus, where it interacts with specific DNA sequences known as androgen response elements (AREs). This interaction modulates gene expression, influencing the synthesis of various proteins that mediate testosterone's physiological actions. (DrugBank).
In some tissues, testosterone is converted into more potent androgens. For instance, in tissues like the prostate, skin, and liver, an enzyme called 5-alpha-reductase converts testosterone into dihydrotestosterone (DHT). DHT has a higher affinity for the androgen receptor than testosterone and is responsible for many androgenic effects, such as prostate growth and hair follicle development. (PubChem).
Conversely, in other tissues, such as adipose tissue and the brain, testosterone can be converted into estradiol (an estrogen) by the enzyme aromatase. Estrogen plays important roles in bone health, cardiovascular function, and cognitive processes in males, highlighting the complex interplay of hormones. The balance between testosterone, DHT, and estradiol, and their respective interactions with their receptors, underpins the diverse biological effects of testosterone throughout the body. (Examine.com)
Testosterone Replacement Therapy (TRT) is primarily used to address symptoms associated with clinically low testosterone levels, or hypogonadism. The benefits observed are generally related to reversing these deficiency symptoms. (NIH National Institute of Diabetes and Digestive and Kidney Diseases).
* **Improved Muscle Mass and Strength:** Testosterone plays a key role in protein synthesis and muscle growth. Studies have shown that TRT can lead to increases in lean muscle mass and improvements in muscle strength in hypogonadal men. (Journal of Clinical Endocrinology & Metabolism).
* **Enhanced Bone Mineral Density:** Testosterone contributes to maintaining bone health. TRT can increase bone mineral density, which may reduce the risk of osteoporosis and fractures in men with low testosterone. (Endocrine Reviews).
* **Improved Mood and Cognitive Function:** Many men with low testosterone report symptoms such as fatigue, depression, and impaired cognitive function. TRT has been associated with improvements in mood, energy levels, and some aspects of cognitive function, although individual responses vary. (Archives of Internal Medicine).
* **Increased Libido and Sexual Function:** Low libido and erectile dysfunction are common symptoms of hypogonadism. TRT can often improve sexual desire, frequency of sexual activity, and erectile function in men with diagnosed testosterone deficiency. (New England Journal of Medicine).
* **Metabolic Benefits:** Some research suggests that TRT may have beneficial effects on metabolic parameters, including reductions in fat mass and improvements in insulin sensitivity, particularly in men with concomitant metabolic syndrome or type 2 diabetes. However, more long-term research is ongoing in this area. (European Journal of Endocrinology).
The efficacy of Testosterone Replacement Therapy (TRT) for diagnosed hypogonadism is supported by a substantial body of clinical research. Multiple randomized controlled trials and observational studies have evaluated the impact of TRT on various health outcomes.
For instance, the Testosterone Trials (TTrials), a series of seven coordinated, double-blind, placebo-controlled trials, provided robust evidence regarding the effects of testosterone gel in older men with low testosterone levels. The TTrials demonstrated significant improvements in sexual function, mood, and some aspects of vitality in men receiving testosterone therapy compared to placebo. (New England Journal of Medicine).
Regarding bone health, a meta-analysis cited by Endocrine Reviews concluded that TRT causes a modest but statistically significant increase in bone mineral density in hypogonadal men. For muscle mass and strength, studies, including those published in the Journal of Clinical Endocrinology & Metabolism, consistently report increases in lean body mass and modest improvements in strength with TRT in deficient individuals.
While evidence supports symptom improvement for clinically diagnosed hypogonadism, the long-term cardiovascular safety of TRT has been a subject of extensive debate and ongoing research. The FDA has mandated labeling changes to include warnings about potential cardiovascular risks. Current consensus among major medical organizations like the Endocrine Society emphasizes individualized risk-benefit assessment and careful monitoring for patients on TRT. (FDA Drug Safety Communication; Endocrine Society Clinical Practice Guidelines).
Testosterone Replacement Therapy (TRT) can lead to various side effects, which range in severity and frequency. These effects are often dependent on the dose, duration of therapy, individual sensitivity, and the specific formulation of testosterone used. (MedlinePlus).
Common side effects may include:
* **Skin reactions:** Acne, oily skin, hair loss (androgenic alopecia), or local irritation at the site of application (for gels or patches).
* **Fluid retention:** Swelling in the ankles or feet, sometimes leading to or worsening hypertension.
* **Changes in blood counts:** Increase in red blood cell count (erythrocytosis or polycythemia), which can lead to increased blood viscosity and potentially heighten the risk of blood clots.
* **Prostate effects:** Growth of the prostate gland (benign prostatic hyperplasia), although evidence for TRT causing prostate cancer is inconclusive, it can accelerate growth of pre-existing prostate cancer.
* **Sleep apnea:** Worsening of pre-existing sleep apnea or induction of new sleep apnea.
* **Mood changes:** Irritability, aggression, or mood swings.
* **Gynecomastia:** Development or enlargement of breast tissue.
* **Testicular atrophy and impaired fertility:** Exogenous testosterone suppresses natural testosterone production, leading to shrinkage of the testicles and reduced sperm count, impacting fertility.
Serious but less common side effects reported in some studies and FDA warnings include potential cardiovascular events (such as heart attack or stroke) and venous thromboembolism (blood clots in the legs or lungs). These risks are subject to ongoing research and debate. Regular monitoring by a healthcare professional is essential to identify and manage potential side effects. (FDA Drug Safety Communication; Mayo Clinic).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Replacement Therapy (TRT) carries several important warnings that necessitate careful consideration and medical supervision. (FDA).
* **Cardiovascular Risk:** The FDA has issued warnings regarding a potential increased risk of cardiovascular events, including heart attack and stroke, associated with testosterone use. While studies have yielded mixed results, patients should be thoroughly evaluated for pre-existing cardiovascular conditions, and monitored closely. (FDA Drug Safety Communication).
* **Polycythemia/Erythrocytosis:** TRT can increase red blood cell count, leading to polycythemia (abnormally high concentration of hemoglobin in the blood), which increases the risk of blood clots, stroke, and heart attack. Regular monitoring of hematocrit and hemoglobin levels is crucial. If levels become too high, dose reduction or temporary cessation of therapy may be required.
* **Prostate Health:** Testosterone can stimulate the growth of prostate tissue. Men receiving TRT should be screened for prostate cancer before initiation and monitored for prostate-specific antigen (PSA) levels and prostatic changes during therapy. TRT is generally contraindicated in men with known or suspected prostate cancer.
* **Sleep Apnea:** TRT may worsen pre-existing sleep apnea or induce new sleep apnea, particularly in older or obese individuals. Patients should be screened for sleep apnea symptoms and monitored during therapy.
* **Fluid Retention:** Testosterone can cause sodium and water retention, leading to edema (swelling), particularly in patients with pre-existing heart, kidney, or liver disease. This can exacerbate conditions like congestive heart failure. (MedlinePlus).
* **Liver Toxicity:** While rare with injectable or topical forms, oral testosterone preparations can be associated with liver toxicity. Liver function should be monitored where appropriate.
* **Fertility Impairment:** Exogenous testosterone suppresses endogenous testosterone production and spermatogenesis (sperm production), leading to temporary or potentially long-term infertility. Men concerned about fertility should discuss this with their clinician before initiating TRT. (Endocrine Society Clinical Practice Guidelines).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Replacement Therapy (TRT) is contraindicated in several conditions due to potential risks or lack of benefit. The decision to initiate TRT requires a thorough medical evaluation by a licensed clinician. (FDA Prescribing Information; Endocrine Society Clinical Practice Guidelines).
Absolute contraindications generally include:
* **Known or suspected prostate cancer:** Testosterone can stimulate the growth of prostate tissue and may accelerate the progression of existing prostate cancer.
* **Known or suspected breast cancer in males:** Similar to prostate cancer, testosterone can promote the growth of breast cancer cells.
* **Severe untreated benign prostatic hyperplasia (BPH) with severe lower urinary tract symptoms:** TRT can worsen urinary symptoms in men with severe BPH.
* **Untreated severe sleep apnea:** TRT can exacerbate sleep apnea.
* **Polycythemia (hematocrit >50%):** Due to the risk of increasing red blood cell count further and increasing blood viscosity and thrombotic risk.
* **Uncontrolled congestive heart failure (class III or IV):** TRT can lead to fluid retention, which may worsen heart failure.
* **Pregnancy or breastfeeding:** Testosterone is a Category X drug in pregnancy and can cause fetal harm. It is also not indicated for use in breastfeeding women.
* **Hypersensitivity:** Known hypersensitivity to any component of the testosterone preparation.
Relative contraindications or conditions requiring extreme caution and close monitoring include a history of cardiovascular events (heart attack, stroke), venous thromboembolism, or significant hepatic or renal impairment. A thorough discussion of risks and benefits with a clinician is crucial for any individual considering TRT. (Mayo Clinic).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Combining Testosterone Replacement Therapy (TRT) with certain medications or substances can lead to adverse interactions, reduced efficacy of one or both compounds, or increased risk of side effects. Always inform your prescribing clinician about all medications, supplements, and herbal products you are currently taking. (MedlinePlus; DrugBank).
* **Anticoagulants (Blood Thinners):** Testosterone can enhance the anticoagulant effect of warfarin and other oral anticoagulants (e.g., phenprocoumon, acenocoumarol). This can increase the risk of bleeding. Close monitoring of INR and dose adjustments of anticoagulants may be necessary.
* **Corticosteroids:** Concomitant administration of testosterone with corticosteroids (e.g., prednisone, dexamethasone) may increase the risk of fluid retention and edema, particularly in individuals with pre-existing cardiac, hepatic, or renal disease.
* **Insulin and Oral Hypoglycemic Agents:** In diabetic patients, testosterone may decrease blood glucose levels, potentially requiring a reduction in the dose of insulin or oral hypoglycemic agents. Close monitoring of blood glucose is recommended.
* **Thyroid Hormones:** Testosterone may decrease levels of thyroid-binding globulin, which can confound thyroid function tests but generally does not alter thyroid hormone efficacy.
* **Diuretics:** Co-administration with diuretics may affect sodium and water balance, potentially exacerbating fluid retention when combined with testosterone.
* **Certain Oral Medications with Hepatic Metabolism:** While less common with injectable or topical TRT, some oral testosterone formulations can interact with drugs metabolized by certain liver enzymes (e.g., CYP3A4 inhibitors/inducers), potentially altering their concentrations.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
The dose of Testosterone Replacement Therapy (TRT) is clinician-directed and must be set by a licensed clinician, tailored to individual patient needs, symptom severity, and desired testosterone levels. The timing and frequency of administration vary significantly based on the specific formulation being used. (FDA Prescribing Information).
* **Testosterone Injections (e.g., enanthate, cypionate):** Injections are typically administered intramuscularly at intervals ranging from every one to four weeks. Common regimens might involve injections every 1-2 weeks. The exact frequency is determined by the clinician based on the half-life of the ester and the patient's response and hormone levels. (DrugBank).
* **Testosterone Gels or Solutions:** These are usually applied topically to the skin once daily, typically in the morning. Application sites generally include the shoulders, upper arms, or abdomen, avoiding areas that could transfer to others.
* **Transdermal Patches:** Patches are typically applied once daily, often at night, and worn for 24 hours before being replaced with a new patch.
* **Buccal Tablets:** These are applied to the gum and adhere to the mucosal surface, releasing testosterone over 12 hours. They are typically replaced every 12 hours.
* **Subdermal Pellets:** Pellets are surgically implanted under the skin, usually in the buttock, and release testosterone consistently over three to six months.
Regardless of the formulation, consistent adherence to the prescribed timing and frequency is crucial for maintaining stable testosterone levels and optimizing therapeutic outcomes. Regular blood tests are performed to monitor testosterone levels (usually trough or peak, depending on formulation) and adjust the dosing regimen as needed. (Mayo Clinic)
What interacts with Testosterone (TRT)?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
| Anastrozole (Arimidex) | Complementary | Compound pairConfidence: theoretical | Aromatase inhibitor controls estradiol conversion from exogenous testosterone.Source pending | Dose AI to target mid-range E2; over-suppression harms joints, mood, and lipids. |
Frequently asked questions about Testosterone (TRT)
Testosterone (TRT) is a hormone. It is also known as trt and testosterone cypionate. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Testosterone (TRT) is commonly discussed in the context of supporting testosterone, brain, libido, and bone-joint. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Testosterone (TRT), it is typically administered by injection and it is typically taken null. Always follow the specific dose your clinician or the product label prescribes.
Testosterone (TRT) carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Testosterone (TRT) is classified as a controlled substance in some jurisdictions, so legal status and prescribing rules apply. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Testosterone (TRT) comes from the rest of the stack: other hormones, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Testosterone (TRT) with no sign-up.
Pairing Testosterone (TRT) with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Testosterone (TRT) varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Testosterone (TRT) depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Testosterone (TRT) the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Verify at
Publisher search links for Testosterone (TRT). These are places to check the information — they are not citations, so they are not numbered.
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Clinical practice guidelines (PubMed)(publisher search, opens in a new tab)National Library of Medicine · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Testosterone (TRT)?
Plain-text summary, safe to quote verbatim:
Testosterone is a steroid hormone primarily produced in the testes of males and, in smaller amounts, in the ovaries of females and the adrenal glands in both sexes. Research on Testosterone (TRT) focuses on testosterone support, cognition and mood, and libido.
Source: DoseRoutine — https://doseroutine.com/library/testosterone-trt
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Testosterone (TRT) — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/testosterone-trt
What compounds are similar to Testosterone (TRT)?
Others in the hormone category or studied for the same goals.
Which goals is Testosterone (TRT) used for?
Other compounds studied for the same benefits as Testosterone (TRT).
Continue exploring
See every compound DoseRoutine catalogs for these goals.